Sanofi sells Dermik dermatology unit to Valeant Pharmaceuticals for $425 million
Client(s) Sanofi
Jones Day advised Sanofi in the sale of its Dermik dermatology unit to Valeant Pharmaceuticals International Inc. for $425 million. Dermik has a significant presence in the medical dermatology market in the United States and Canada.
In addition to M&A representation, Jones Day provided intellectual property, antitrust, and employee benefits advice regarding this transaction.